A Study of a Hydrocolloid Bandage on Pimples
Public ClinicalTrials.gov record NCT05012735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Evaluation of the Safety and Efficacy of a Hydrocolloid Bandage on Pimples
Study identification
- NCT ID
- NCT05012735
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
- Industry
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
- Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) Drug
- Prototype Ultrathin Hydrocolloid Bandage Device
Drug · Device
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 18, 2021
- Primary completion
- Sep 12, 2021
- Completion
- Sep 12, 2021
- Last update posted
- Sep 15, 2022
2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SGS Stephens Inc. | Richardson | Texas | 75081 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05012735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05012735 live on ClinicalTrials.gov.